top of page
Medical Consulting
Clinic M&A
Early-stage investment
Daichiku Medical Group
We are
a leading early-stage
investor in Japan, focusing on
Biotechnology,
Health Care
2
We continue to create
great value for our portfolio companies.
3
Philosophy
Professionalism of founders
Profit maximization
Progressive business plan
providing a good opportunity to the greatest number
Strategy
We discover and support plans that have the potential to build Global Competitiveness.
We have built a Balanced Portfolio of
Biotech/Healthcare
Our Experts evaluate the Potential and Feasibility of candidate plans.
Founders
Kenneth Lee
CEO/Founder/Medical Doctor
Kenneth is a CEO/Founder at Daichiku Group and the leader of our Healthcare / Biotechnology practice. Functionally, He works across Therapeutics industries, Medical Affairs, Strategy, digital and analytics.
He studied at Tokyo medical and dental university (TMDU), Faculty of Medicine as a Japanese Government Scholarship Student.
He worked in leading healthcare start-up company in Japan and also established a Consulting firm specialized in offshore administration and marketing between Korea and Japan
5
Directors
Kwak E.S.
Director
Julie Kwak, based in Seoul, is director and leading Our Professional Services.
She works with portfolio companies in Korea across finance, M&A Advisory, Accounting, Strategy and Investment functions to identify creative solutions, new opportunities and practical strategies.
She studied at Yonsei University in Seoul, South Korea.
Kyungmoo Lee
Director
K.M Lee, based in Seoul, is director and leading Our Professional Services.
He has strong knowledge about finance and investment in wide variety of the field. He studied at Gachon University in Seongnam, South Korea.
Where we're
Seoul, South Korea
Singapore
Tokyo, Japan
4
bottom of page